CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 141 filers reported holding CLOVIS ONCOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $13,345,000 | +21.4% | 161,958 | +37.9% | 0.05% | +18.2% |
| Q2 2017 | $10,995,000 | +302.7% | 117,428 | +173.9% | 0.04% | +300.0% |
| Q1 2017 | $2,730,000 | +60.1% | 42,870 | +11.7% | 0.01% | +57.1% |
| Q4 2016 | $1,705,000 | +129.5% | 38,385 | +86.1% | 0.01% | +133.3% |
| Q3 2016 | $743,000 | +162.5% | 20,623 | 0.0% | 0.00% | +200.0% |
| Q2 2016 | $283,000 | -17.5% | 20,623 | +15.4% | 0.00% | 0.0% |
| Q1 2016 | $343,000 | -46.7% | 17,869 | -2.8% | 0.00% | -66.7% |
| Q4 2015 | $644,000 | -93.0% | 18,393 | -81.6% | 0.00% | -92.7% |
| Q3 2015 | $9,213,000 | +550.2% | 100,189 | +521.3% | 0.04% | +583.3% |
| Q2 2015 | $1,417,000 | -44.2% | 16,126 | -52.9% | 0.01% | -40.0% |
| Q1 2015 | $2,541,000 | +118.7% | 34,226 | +65.0% | 0.01% | +100.0% |
| Q4 2014 | $1,162,000 | +22.1% | 20,743 | -1.2% | 0.01% | +25.0% |
| Q3 2014 | $952,000 | +9.7% | 20,998 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $868,000 | -18.3% | 20,973 | +36.7% | 0.00% | -20.0% |
| Q1 2014 | $1,062,000 | +27.2% | 15,337 | +10.7% | 0.01% | +66.7% |
| Q4 2013 | $835,000 | +8.2% | 13,858 | +9.1% | 0.00% | 0.0% |
| Q3 2013 | $772,000 | +10.4% | 12,704 | +21.7% | 0.00% | -25.0% |
| Q2 2013 | $699,000 | – | 10,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |